Maintains Buy Rating
https://www.marketscreener.com/news/hc-wainwright-adjusts-nektar-therapeutics-price-target-to-135-from-120-maintains-buy-rating-ce7d50dedf8bfe24
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.